Technical Analysis for EXAI - Exscientia Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -1.13% | |
| Pocket Pivot | Bullish Swing Setup | -1.13% | |
| Outside Day | Range Expansion | -1.13% | |
| Wide Bands | Range Expansion | -1.13% | |
| Up 3 Days in a Row | Strength | -1.13% | |
| Wide Bands | Range Expansion | 1.64% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.30% | |
| Inside Day | Range Contraction | 3.30% | |
| Wide Bands | Range Expansion | 3.30% | |
| 180 Bearish Setup | Bearish Swing Setup | 10.02% |
| Alert | Time |
|---|---|
| Down 3% | about 5 hours ago |
| 60 Minute Opening Range Breakdown | about 5 hours ago |
| 2x Volume Pace | about 6 hours ago |
| 1.5x Volume Pace | about 6 hours ago |
| Down 2 % | about 6 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/21/2024
Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.12 |
| 52 Week Low | 3.86 |
| Average Volume | 632,346 |
| 200-Day Moving Average | 5.76 |
| 50-Day Moving Average | 5.16 |
| 20-Day Moving Average | 4.65 |
| 10-Day Moving Average | 4.90 |
| Average True Range | 0.35 |
| RSI (14) | 54.55 |
| ADX | 19.74 |
| +DI | 18.90 |
| -DI | 21.86 |
| Chandelier Exit (Long, 3 ATRs) | 4.26 |
| Chandelier Exit (Short, 3 ATRs) | 4.91 |
| Upper Bollinger Bands | 5.41 |
| Lower Bollinger Band | 3.90 |
| Percent B (%b) | 0.82 |
| BandWidth | 32.33 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.10 |
| MACD Histogram | 0.0868 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.58 | ||||
| Resistance 3 (R3) | 5.53 | 5.33 | 5.51 | ||
| Resistance 2 (R2) | 5.33 | 5.22 | 5.36 | 5.48 | |
| Resistance 1 (R1) | 5.23 | 5.14 | 5.28 | 5.28 | 5.45 |
| Pivot Point | 5.03 | 5.03 | 5.06 | 5.06 | 5.03 |
| Support 1 (S1) | 4.93 | 4.92 | 4.98 | 4.98 | 4.81 |
| Support 2 (S2) | 4.73 | 4.84 | 4.76 | 4.78 | |
| Support 3 (S3) | 4.63 | 4.73 | 4.76 | ||
| Support 4 (S4) | 4.68 |
